ストックスクリーナーアプリを入手
3.51
0.14%
0.010
Briacell Therapeutics Corp (BCTX) 最新ニュース
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT - Investing News Network
BriaCell engages consultants for Bria-IMT commercialization planning - Investing.com
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™ - The Manila Times
BriaCell taps CRA and Kaleio for Bria-IMT launch planning - Stock Titan
Why did BCTX stock surge 50% today? - MSN
Number of shareholders of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to book forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView
Price to earnings forward of BriaCell Therapeutics Corp – TSX:BCT - TradingView
Price to sales forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView
Price to earnings forward of BriaCell Therapeutics Corp. – BOATS:BCTXZ - TradingView
Enterprise value to revenue forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView
Price to sales forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView
Enterprise value to EBITDA forward of BriaCell Therapeutics Corp. – NASDAQ:BCTX - TradingView
BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisition - TradingView
BriaCell (NASDAQ: BCTX) unit BriaPro posts loss and acquires sCD80 license - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
What Does BriaCell's Latest Offering Mean for Shareholders - Kavout | AI
BriaCell Therapeutics Corp Actuals & Estimates (TSX:BCT) - TradingView
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT - marketscreener.com
BriaCell (BCTX) Partners with Uneedle for Microneedle Technology Development - GuruFocus
BriaCell plans microneedle delivery scale-up for breast cancer drug - Stock Titan
Beyond the Syringe: How Microneedles Could Redefine Cancer Care - BriefGlance
Briacell Therapeutics Corp (BCTX) Institutional Confidence - TradingKey
Briacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Briacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Briacell Therapeutics Corp (BCTXW) Institutional Confidence - TradingKey
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Briacell Therapeutics Corp (BCTXW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Briacell Therapeutics Corp (BCTXW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Briacell Therapeutics Corp (BCTXW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Briacell Therapeutics Corp (BCTXW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Briacell Therapeutics Corp (BCTXW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Briacell Therapeutics Corp (BCTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Briacell Therapeutics Corp (BCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Briacell Therapeutics Corp (BCTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Briacell Therapeutics Corp (BCTXW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Briacell Therapeutics Corp (BCTXW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Briacell Therapeutics Corp - TradingKey
Why Briacell Therapeutics Corp stock is rising today - Wealth Awesome
Why Briacell Therapeutics Corp stock is plummeting today - Wealth Awesome
BCTXZ SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
BCTX Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift Shares Amid Revenue AbsenceROE Trend Analysis - newsline.com
BriaCell (NASDAQ: BCTX) ramps cancer trials but flags going concern risk - Stock Titan
BriaCell Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2026 - marketscreener.com
BriaCell receives FDA clearance for breast cancer therapy trial - Investing.com
BriaCell Therapeutics Completes Equity Offering to Fund Operations - The Globe and Mail
Immunotherapy Innovations: Increasing Survival in Metastatic Breast Cancer - Investing News Network
BriaCell (NASDAQ: BCTX) completes $4.71M best efforts common share sale - Stock Titan
BriaCell Therapeutics Prices $4.71 Million Share Offering at $3.25; ThinkEquity as Placement Agent - TradingView
Beyond the Lab: Top-Tier Clinical Validation in Biotech Investing - Investing News Network
BriaCell Therapeutics Rises After Hours as It Closes a $4.7-Million Share Offering - Moomoo
BriaCell Therapeutics Closes $4.7 Million Share Offering - marketscreener.com
BriaCell Therapeutics Announces Closing of Offering - Investing News Network
BriaCell Therapeutics (BCTX) raises ~$3.94M net in $3.25 share placement - Stock Titan
BriaCell Presents Positive Clinical Data at ASCO 2026 - Sahm
BriaCell Presenting Final Phase 2, Ongoing Phase 3 Data at ASCO Meeting - Moomoo
BriaCell Therapeutics Prices $4.7 Million Share Offering - Moomoo
1.16%
0.48%
大文字化:
|
ボリューム (24 時間):